Clinical trial

The Effect of Allopurinol on Insulin Resistance and Blood Pressure

NCT00639756

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Allopurinol Normalized identity: allopurinolView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

The Effect of Allopurinol on Insulin Resistance and Blood Pressure

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-06-01

PhasePHASE2

Conditions

Metabolic Syndromeverified · MONDO: abdominal obesity-metabolic syndrome

Interventions

AllopurinolDRUG · verified · RxNorm: allopurinol

PlaceboDRUG

Sponsors & collaborators

Hospital Mateo Orfilalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00639756 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.